Member of the board since 2020.
MSc. in technical physics from the University of Technology in Trondheim, Norway and training in business economics and financial analysis.
Svein Mathisen has more than 30 years of experience in management, business development and financing from the life science industry. He has worked with new product development in all types of organizations: startups, medium and large organizations. He has extensive experience in building teams and organizations, creating and building strategic alliances, raising capital, private and public, as well as most aspects of product development in the life science space. In addition, by leading a publicly listed company (Bioinvent) as CEO for twelve years, he has gained insight into all aspects of what is required to manage such a business.
Board member BalticgrChairman of the Board of iCell Science AB. Board member of Arild Capital AB, Betagenon AB and Betagenon Bio AB.
HOLDINGS (23 Jan 2023)
45 000 shares and 22 500 warrants.
Independent of the Company, its senior executives and major shareholders